Systematic review / meta-analysis / 2021
Meta-analyses of human trials found no statistically significant effect of resveratrol, grape, or wine treatment on cognition, mood, or blood pressure.
Researchers conducted a systematic review and meta-analysis comparing animal and human studies on resveratrol published before January 2020. While most animal model publications reported positive outcomes on cognition and brain function, 11 meta-analyses of human trials comparing placebo to resveratrol, grape, or wine treatment found no statistically significant effect across various measures, including cognitive and mood assessments, grey matter volume, and blood pressure. The authors concluded that the promising effects seen in animals are not replicated in human trials, and any cognitive effects in humans are likely small.
- Study type
- Systematic review and meta-analysis of clinical trials and animal studies
- Who was studied
- Human clinical trials (and animal models) published prior to January 2020
- What was measured
- Cognition, mood assessments, grey matter volume, and blood pressure
THE PAPER
Resveratrol: A "miracle" drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis.
Khorshidi F, Poljak A, Liu Y, Lo JW, Crawford JD, Sachdev PS. Ageing Res Rev, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.